Kebriaei, P <br/><br/>
Allogeneic hematopoietic stem cell transplantation after rituximab-containing myeloablative preparative regimen for acute lymphoblastic leukemia.  [electronic resource] 

 -  Bone marrow transplantation  Aug 2006 
 - 203-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1705425  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Burkitt Lymphoma--therapy<br/>Chi-Square Distribution<br/>Female<br/>Graft vs Host Disease--prevention & control<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Middle Aged<br/>Precursor B-Cell Lymphoblastic Leukemia-Lymphoma--therapy<br/>Rituximab<br/>Statistics, Nonparametric<br/>Survival Analysis<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Treatment Outcome